VJOncology is committed to improving our service to you

ASCO 2019 | Cytoreductive nephrectomy in mRCC

VJOncology is committed to improving our service to you

Bradley McGregor

Here, Bradley McGregor, MD, of the Dana-Farber Cancer Institute, Boston, MA, discusses the role of cytoreductive nephrectomy in metastatic renal cell carcinoma (mRCC). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter